If so, you’re far from alone, with an EPG Health study finding collecting such insights is the No. 1 strategic HCP engagement priority for the coming year. EPG Health surveyed 134 people working at pharma companies, as well as almost 300 HCPs and about 100 service ...
For the past 40 years detailing has been the backbone of pharma/HCP communication – but what about e-detail?
EU proposal focuses on a subset of underserved rare diseases—exploring the gaps in those conditions for which there is no approved treatment option. The EU Regulations Catching US Pharma Companies Off Guard Anna Pinsky, MD, PhD;Elina Smirnova ...
Data integrity is underpinned by the first brick, the metrological integrity of the instrument or system’s operational performance, with demonstrable assurance that it is “fit for intended use” within a specific analytical procedure, which is “fit for intended purpose” over the data lifecycle. ...
EU proposal focuses on a subset of underserved rare diseases—exploring the gaps in those conditions for which there is no approved treatment option. The EU Regulations Catching US Pharma Companies Off Guard Anna Pinsky, MD, PhD;Elina Smirnova ...
In addition to relying on the power of exosomes to provide information otherwise found only through a tissue biopsy, The ExoDx Prostate Test is unique in the following ways: Excludes PSA from the analytic algorithm Targets prostate cancer-specific biomarkers (ERG, PCA3 and SPDEF) ...
How Does Pharmaceutical Omnichannel Marketing Work in Pharma? If multichannel aims to reach as many potential customers as possible, the omnichannel strategy requires a more tactical and on-point approach. A typical modern HCP is usually someone who highly values their time and has no wish to di...
gsksource.com/pharma/content/dam/GlaxoSmithKline/US/en/Prescribing_Information/Engerix-B/pdf/ENGERIX-B.PDF. Accessed April 25, 2019. Recommended child and adolescent immunization schedule for ages 18 years or younger, United States, 2019. CDC website. cdc.gov/vaccines/schedules/hcp/imz/child-...
The patient & physician journey has been disrupted. What will treatment pathway look like in new normal? How pharma marketers can adapt to emerging needs
EU proposal focuses on a subset of underserved rare diseases—exploring the gaps in those conditions for which there is no approved treatment option. The EU Regulations Catching US Pharma Companies Off Guard Anna Pinsky, MD, PhD;Elina Smirnova ...